GT Biopharma (GTBP) Return on Capital Employed Growth (5y) (2016 - 2026)
GT Biopharma (GTBP) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,852.00 |
| Dec 31, 2025 | -29,097.00 |
| Sep 30, 2025 | -14,360.00 |
| Jun 30, 2025 | 11,990.00 |
| Mar 31, 2025 | 694,378.00 |
| Dec 31, 2024 | 361,691.00 |
| Mar 31, 2024 | 230,760.00 |
| Dec 31, 2023 | 193,484.00 |
| Sep 30, 2023 | 6,399.00 |
| Jun 30, 2023 | -8,207.00 |
| Mar 31, 2023 | -7,959.00 |
| Dec 31, 2022 | -9,858.00 |
| Sep 30, 2022 | -8,728.00 |
| Jun 30, 2022 | -22,042.00 |
| Mar 31, 2022 | -20,574.00 |
| Dec 31, 2021 | -29,214.00 |
| Sep 30, 2021 | -15,154.00 |
| Jun 30, 2021 | -15,480.00 |
| Mar 31, 2021 | -21,855.00 |
| Mar 31, 2019 | -249,140.00 |